The HPRA advises healthcare professionals not to retain printed versions of Summary of Product Characteristics (SPC) documents. As these documents are subject to frequent content updates, including changes to safety and dose related information, we recommend that you visit our website as necessary to access the most up-to-date versions. If you have any queries about specific SPCs on our website then please e-mail info@hpra.ie


Naloxone 400 micrograms/ml solution for injection/infusion

400
microgram(s)/millilitre Solution for injection/infusion


B. Braun Melsungen AGPA0736/026/001

Main Information

Trade NameNaloxone 400 micrograms/ml solution for injection/infusion
Active SubstancesNaloxone hydrochloride
Strength400
microgram(s)/millilitre
Dosage FormSolution for injection/infusion
Licence HolderB. Braun Melsungen AG
Licence NumberPA0736/026/001

Group Information

ATC CodeV03AB Antidotes
V03AB15 naloxone

Status

Authorised/WithdrawnAuthorised
Licence Issued19/12/2007
Legal statusProduct subject to prescription which may not be renewed (A)
Supply StatusSupply through pharmacies only
Advertising StatusAdvertising to healthcare professionals only
Conditions of Licence
Marketing StatusNot marketed

Documents

Summary of Product CharacteristicsPDF Version
Package LeafletPDF Version
Public Assessment ReportNo document available
« Back